The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
GLAUKOS CORP COM 377322102   818,985 16,347 SH   SOLE   16,347 0 0
DARE BIOSCIENCE INC COM 23666P101   64,548 62,065 SH   SOLE   62,065 0 0
THE REALREAL COM 88339P101   2,966,141 2,354,080 SH   SOLE   2,354,080 0 0
PMV PHARMACEUTICALS INC COM 69353Y103   7,703,125 1,614,911 SH   SOLE   1,614,911 0 0
SERA PROGNOSTICS CLASS A COM 81749D107   9,254,203 2,416,241 SH   SOLE   2,416,241 0 0